1 / 12

Heparanase in diabetic nephropathy: Mode of action and therapeutic implications

Heparanase in diabetic nephropathy: Mode of action and therapeutic implications. Dr. Tzahi Neuman. Cloning the Heparanase. Vlodavsky et al. Nat Med. 1999 Jul ;5(7):793-802. Hulett MD, Parish CR. Nat Med. 1999 Jul ;5(7):803-9.

edmund
Download Presentation

Heparanase in diabetic nephropathy: Mode of action and therapeutic implications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Heparanase in diabetic nephropathy: Mode of action and therapeutic implications Dr. Tzahi Neuman

  2. Cloning the Heparanase Vlodavsky et al. Nat Med. 1999 Jul;5(7):793-802. Hulett MD, Parish CR. Nat Med. 1999 Jul;5(7):803-9. Kussie et al. BiochemBiophysRes Commun. 1999 Jul22;261(1):183-7. Toyoshima M, Nakajima M. J Biol Chem. 1999 Aug 20;274(34):24153-60

  3. Heparan-sulfate (HS) glycosaminoglycans at the cell surface and in the ECM • HS is a key element in the self-assembly, and barrier properties of the ECM (particularly, BM). • HS is responsible for sequestration of the heparin-binding growth factors (i.e., bFGF, VEGF, KGF) in the ECM. Adapted from Sasisekharan et al., Nature Reviews Cancer 2002

  4. Heparanase Activity Enables cell movement through extracellular barriers during the processes involving cell migration (i.e., tumor invasion, implantation, extravasation of blood borne cells, etc). Releases heparan sulfate-bound GF from ECM depots, making them available for growth factor-dependent processes (i.e., tumor growth, neovascularization, wound healing).

  5. Processing and activation of pro-heparanase by Cathepsin L + + + - + + - - + Pro-Hpa 65 kDa Cathepsin L Cathepsin L inhibitor 65 kDa 65 kDa Processing 50 kDa 50 kDa 8 kDa 8 kDa

  6. The role of heparanase in Diabetic Nephropathy using the STZ model

  7. Changes in heparanase expression, HS content, and albuminuria in WT&KO mice in response to STZ-induced diabetes.

  8. Histopathologic changes in the kidneys of WT&KO mice in response to STZ-induced diabetes.

  9. Effect of heparanase inhibitor on albuminuria and renal damage in diabetic mice.

  10. Effect of Heparanase inhibitor on albuminuria and TGFb expression

  11. Summary Heparanase is a predominant mammalian enzyme that cleaves heparansulfate Heparanase is overexpressed in the diabetic kidney There is essential involvement of heparanase in the pathogenesis of DN. Deletion of the heparanase gene protects diabetic mice from diabetic nephropathy (DN). Heparanaseinhibitor decreases the extent of albuminuria.

  12. Summary (continue) Heparanase enhances macrophage and thus increases the kidney-damaging properties of macrophages. This findings will help in developing effective strategies to disrupt the heparanase-driven sequence of events in diabetic kidney disease, and in designing novel therapeutic interventions in DN

More Related